Statins protect from death from pneumonia
Because hospitalized patients with pneumonia had a lower risk of dying from the disease if they took cholesterol-lowering statins, the widely used prior to admission. These results suggest that research published today in the open access journal Respiratory another beneficial use of statins are prescribed to an increasing number of patients to prevent and treat high cholesterol, diabetes, heart disease and vascular.Death from infection in the United States, where it kills 40,000 people a year - the most vulnerable children, the elderly and patients with health problems such as AIDS or chronic obstructive pulmonary disease (COPD). The disease is caused by viruses or bacteria that are resistant to antibiotics used against bacterial cause pneumonia.
Inflammation of the
lungs, statins before hospitalization. They compared the risk of dying from the disease in patients with pneumonia who were not treated with statins. The authors used the pneumonia severity index for the risk of dying within 30 days of hospitalization in both groups of patients evaluated. The results of statistical analysis show that patients treated with statins when they reached the hospital to die, 2.8 times less likely than patients not taking statins.Prior outpatient statin therapy reduces mortality in patients with community-acquired pneumonia despite their use will help with co-morbid diseases may lead to increased mortality, the authors write in the associated hospital stay in touch. Further research is needed to explain the protective effect of statins in patients
with pneumonia. Statins act on the cholesterol-regulating enzyme HMG-CoA reductase, but they are also known to affect the immune system, and this may explain their effect on pneumonia patients.Based on this article: The effect of prior statin use on 30-day mortality for patients hospitalized with community-acquired pneumonia Eric M. Mortensen, Marcos I.
obliged to open access to peer-reviewed research in
Pages: [1] 2